At Rabin Medical Center, patients can access comprehensive Castleman Disease Treatment supported by advanced diagnostic facilities and experienced specialists. Established in 1996, the JCI accredited hospital is located in Petah Tikva, Israel, and has 1300 beds.

Castleman disease treatment is tailored according to whether the condition is unicentric or multicentric and whether an underlying infection or immune disorder is present. Surgery may be used for localised disease, while multicentric forms may require antibody-based therapy, corticosteroids, chemotherapy, or treatment of an associated condition. A thorough diagnostic assessment guides treatment selection.